Ruth finished school in Brazil and studied medicine at the University of São Paulo (USP), where she met her classmate Victor Nussenzweig, who would become her husband, life companion, and scientific collaborator for more than 65 years; their marriage ceremony was in the Department of Parasitology library at the medical school in 1952. As medical students Ruth and Victor conducted research on Trypansoma cruzi, the cause of Chagas Disease. In a 1953 publication they reported that gentian violet destroyed T. cruzi in infected blood. Based on their work, gentian violet was adopted as preventative treatment of blood targeted for human transfusion in Brazil and other Latin American countries, an amazing contribution by medical students that foreshadowed what was to come.
In While making the seminal findings described at the outset, Dr. Nussenzweig built and trained an incredible team of scientists at NYU, many of whom became internationally renowned leaders. Her NYU team systematically described the immunological mechanisms responsible for the protection induced by irradiated sporozoites, and created reagents used for studying the epidemiology of malaria in the field. Most of the early work focused on antibodies to sporozoites and specifically CSP. However, she and Victor subsequently led studies that also established roles for cellular immunity in mediation of protective immunity. She and her team trained scores of students and fellows from all over the world, many of whom became leaders in the field. This included many from Brazil, where Ruth, along with Victor, maintained scientific relations. Starting in 2012, she and Victor returned to do research in Brazil for some months each year, at the Federal University of São Paulo.
Ruth published her groundbreaking work in the most prestigious scientific journals. For example, in 1967 For example, in , 1968 For example, in , 1969 For example, in , and 1970 she published scientific articles in Nature, and in total she published more than 230 scientific papers. She published 22 articles in the American Journal of Tropical Medicine and Hygiene. She received numerous awards in the U.S., Europe, and Brazil, including the Paul-Ehrlich and Ludwig Darmstaedter Prize (Germany); the Joseph Augustin LePrince Medal, in recognition of outstanding work in the field of malariology from the American Society of Tropical Medicine and Hygiene (ASTMH) in 1997; the Denis Thienpont Prize from the Royal Academy of Medicine of Belgium; the Gold Medal from the Sabin Vaccine Institute; the Warren Alpert Foundation Award from Harvard; and most recently in 2017, the inaugural Clara Southmayd Ludlow Medal of the ASTMH, named for a woman leader in the field of tropical medicine. Ruth was an active member of the ASTMH, which she joined in 1965. She was selected as a member/fellow of numerous honorific societies including the Royal Academy of Medicine of Belgium, the Brazilian Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine (USA), and National Academy of Science (USA).
Ruth Sonntag Nussenzweig was a unique force, a visionary, a leader, and a brilliant scientist, who made her mark despite having to move at critical times in her formative years from Nazi-ruled Austria and then from military-dominated Brazil to the United States. Ruth Nussenzweig was a pioneer, whose efforts provided the foundation for the development of malaria vaccines now on the horizon, to help rid the world of a disease that still causes illness in over 200 million and death in a half million people each year. She is survived by her husband, Victor, her three children, Michel, Sonia, and Andre, all highly successful and renowned academics undoubtedly inspired by their mother (and father), and six grandchildren. Dr. Nussenzweig will be greatly missed, but she lives on through her prodigious scientific contributions and her many students, trainees, and colleagues who continue to contribute valuable tropical medicine research. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dr. Nussenzweig was the first recipient of ASTMH's Clara Southmayd Ludlow Medal.
